ST Pharm
ST Pharm
  • 01Who we are
  • 02Our record
  • 03Newsroom
  • 04Contact
    • En
    • Ko
ST Pharm
  • Science & Technology
    • Business Overview
    • CDMO
      • Small Molecule
      • Oligonucleotide
      • mRNA
    • CRO
      • AnaPath Research & Service
    • R&D
      • Virtual R&D
      • Global R&D
  • About
    • ST PHARM
    • Key Members
    • History
    • Global Approval
    • ST Pharm Family
    • CI
  • Public
    • PR (Public Relations)
      • News room
        • All
        • Media Focus
        • ST PHARM News
    • IR (Investor Relations)
      • Stock Information
      • IR Library
        • Disclosure Information
        • IR Materials
        • Notice
  • Careers
  • ESG
    • Update in progress
  • Sitemap
  • Linkedin
Public
IR Materials
  • PR (Public Relations)
    • News room
      • All
      • Media Focus
      • ST PHARM News
  • IR (Investor Relations)
    • Stock Information
    • IR Library
      • Disclosure Information
      • IR Materials
      • Notice

IR Library

  • Disclosure Information
  • IR Materials
  • Notice
[IR Material] Korea Investors Relation Service IR Event (translated version) Dec 18, 2025
[IR Material] Daol Securities NDR Nov 3, 2025
[Earning Call] 2025 3rd Quarter Earning Call Presentation Material/Transcript Oct 29, 2025
[IR Material] KIS Global Investors Conference 2025 (Seoul) Sep 12, 2025
[IR Material] Mirae Asset Securities NDR (Hong Kong / Singapore) Aug 13, 2025
[Earning Call] 2025 2nd Quarter Earning Call Presentation Material/Transcript Jul 24, 2025
[Earning Call] 2025 1st Quarter Earning Call Presentation Material/Transcript Apr 29, 2025
KIS Korea Investors Conference 2025 Feb 17, 2025
[Earning Call] 2024 4rd Quarter Earning Call Presentation Material Feb 10, 2025
[Update] IR Material based on 3Q Quarterly Report Nov 19, 2024
[IR Material] Macquarie Securities Korea NDR (Hong Kong / Singapore) Nov 1, 2024
[Earning Call] 2024 3rd Quarter Earning Call Presentation Material Nov 1, 2024
[IR Material] Korea Investment Week 2024 Sep 6, 2024
[IR Materials] mRNA Platform Technology Mar 14, 2023
1of3
HOMEPublicIR (Investor Relations)IR LibraryIR Materials
  • Science & Technology
    • Business Overview
    • CDMO
      • Small Molecule
      • Oligonucleotide
      • mRNA
    • CRO
      • AnaPath Research & Service
    • R&D
      • Virtual R&D
      • Global R&D
  • About
    • ST PHARM
    • Key Members
    • History
    • Global Approval
    • ST Pharm Family
    • CI
  • Public
    • PR (Public Relations)
      • News room
        • All
        • Media Focus
        • ST PHARM News
    • IR (Investor Relations)
      • Stock Information
      • IR Library
        • Disclosure Information
        • IR Materials
        • Notice
  • Careers
  • ESG
    • Update in progress
  • Privacy Policy
  • Terms of Use
  • Sitemap
  • Linkedin
© 2026 ST Pharm. All rights reserved.
  • Sitemap

We care about your privacy

This site uses essential cookies necessary for the operation of the service and for maintaining your language preferences. For more information, please review our Privacy Policy and Terms of Service.